Zoetis Downgraded to Market Perform by Leerink Analyst Daniel Clark
PorAinvest
jueves, 17 de julio de 2025, 11:59 pm ET1 min de lectura
PIPR--
The move comes amidst a mixed bag of analyst ratings for Zoetis. While several analysts have maintained a positive outlook on the stock, others have adjusted their ratings. For instance, Piper Sandler increased their target price from $205 to $210 and gave the stock an "overweight" rating [1]. Meanwhile, Stifel Nicolaus cut its rating from "buy" to "hold" and lowered the price target from $165 to $160 [1]. UBS Group also reduced their target price from $189 to $170 and set a "neutral" rating [1].
Zoetis reported strong earnings for the first quarter of 2025, with 9% organic operational revenue growth led by the International segment. The Companion Animal portfolio also saw 9% operational growth, driven by sustained demand for market-leading franchises. However, the company faced challenges in the US Livestock segment, which experienced a 2% organic operational decline due to aggressive price competition and timing of price adjustments [2].
The downgrade by Leerink Partners suggests that investors should be cautious about Zoetis' near-term prospects. However, the company's strong earnings performance and global scale may provide a buffer against potential headwinds. As always, investors should conduct thorough research and consider their risk tolerance before making investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/zoetis-nysezts-downgraded-by-leerink-partners-to-market-perform-2025-07-17/
[2] https://www.gurufocus.com/news/2983345/zoetis-zts-downgraded-to-market-perform-by-analyst-zts-stock-news
UBS--
ZTS--
Leerink analyst Daniel Clark downgraded Zoetis (ZTS) to Market Perform from Outperform with a $155 price target.
Zoetis (NYSE:ZTS) has been downgraded to a "Market Perform" rating by Leerink analyst Daniel Clark, who previously had the stock rated as "Outperform." The analyst has set a new price target of $155 for the stock [1]. This downgrade reflects a more cautious outlook on the company's future performance, indicating that Zoetis might not surpass broader market expectations.The move comes amidst a mixed bag of analyst ratings for Zoetis. While several analysts have maintained a positive outlook on the stock, others have adjusted their ratings. For instance, Piper Sandler increased their target price from $205 to $210 and gave the stock an "overweight" rating [1]. Meanwhile, Stifel Nicolaus cut its rating from "buy" to "hold" and lowered the price target from $165 to $160 [1]. UBS Group also reduced their target price from $189 to $170 and set a "neutral" rating [1].
Zoetis reported strong earnings for the first quarter of 2025, with 9% organic operational revenue growth led by the International segment. The Companion Animal portfolio also saw 9% operational growth, driven by sustained demand for market-leading franchises. However, the company faced challenges in the US Livestock segment, which experienced a 2% organic operational decline due to aggressive price competition and timing of price adjustments [2].
The downgrade by Leerink Partners suggests that investors should be cautious about Zoetis' near-term prospects. However, the company's strong earnings performance and global scale may provide a buffer against potential headwinds. As always, investors should conduct thorough research and consider their risk tolerance before making investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/zoetis-nysezts-downgraded-by-leerink-partners-to-market-perform-2025-07-17/
[2] https://www.gurufocus.com/news/2983345/zoetis-zts-downgraded-to-market-perform-by-analyst-zts-stock-news

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios